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Background:  Stem cell therapy for ischemic cardiomyopathy offers the promise of myocardial regeneration for patients refractory to traditional 
treatments. Serial coronary flow reserve (CFR) should improve after stem cell delivery but has traditionally been measured invasively. Relative uptake 
alone by PET or SPECT might miss absolute changes in flow.
Methods:  Ischemic cardiomyopathy patients with EF<40% and no options for mechanical revascularization were enrolled in an open-label phase 
II study of intramyocardial, autologous CD34+ cell therapy. Baseline and 6 month non-invasive CFR were performed using rest-dipyridamole stress 
PET with absolute flow quantification in cc/g/min. After the baseline PET scan, patients underwent mobilization and plasmaphoresis harvesting of 
autologous CD34+ cells. Intramyocardial delivery in the catheterization laboratory was guided by 3D NOGA mapping of the LV. The corresponding 
treated region was identified on the PET map.
Results:  2 patients underwent serial CFR measurements. Relative uptake improved in the treated region both at rest and stress. However, CFR 
distinguished between a patient who responded with a >30% increase in CFR (#1) and a patient without response in CFR (#2).
Conclusions:  Changes in CFR by PET might offer a superior endpoint for the success of stem cell therapy, given its non-invasive nature and ability 
to quantify flow absolutely. 
Patient Time PET CFR % change Rest uptake % change Stress uptake % change
1
Baseline 2.01 75% 71%
6 month 2.66 +32% 82% +9% 75% +6%
2
Baseline 1.28 59% 56%
6 month 1.26 -2% 60% +2% 58% +4%
